Pyrrolo[2,3-d]pyrimidine nucleoside analogs
US6831069B2 · kind B2 · utility
41Cited by
4References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 28, 2001 |
| Grant date | Dec 14, 2004 |
| Priority date | — |
| Expiry date | Feb 28, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for pyrrolo[2,3-d]pyrimidine nucleoside analogs having substituents at the C4′ and C5′ positions of the ribofuranose moiety are presented. Contemplated compositions exhibit, among other things, anti-cancer and immunomodulating effects at reduced cytotoxicity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.